Hybrid Meeting 2021
18 November 2021
SHARP for over 30 years has been at the forefront of the prevention of cardiovascular disease in Scotland. As we emerge from the effects of the COVID-19 pandemic our exciting educational programme continues with our November 2021 meeting.
Atrial fibrillation is a major risk factor for stroke. We will address both its detection and management, how to balance the benefit of prevention versus the risks and what is new in respect of national clinical guidance. The long term mortality and morbidity effects of coronary artery disease remains a major problem for society so it is both appropriate and important using a personalised approach, to examine recent therapeutic developments of heart failure in improving clinical outcomes.
We have become accustomised in the past two years to the benefits of technology enhanced consulting but wearable technology in the detection of heart disease continues to develop apace. Those attending the meeting will learn the role of technology in diagnosis and importantly what to do when faced with a printout from a patient using the latest ‘gizmo’.
We always need to look forward and more especially after a difficult two years. We are fortunate to have as a speaker, a worldwide expert of how the use of data will inform the management of patients with heart and vascular disease in the years ahead.
Finally, we are very proud of our continuing role in promoting the SHARP prize in the field of cardiovascular disease in order to showcase the work of young health professionals and helping to support and enhance their careers.
Dr. Ander Cohen - An update on VTE for Cardiologists
Prof Lis Neubeck - Community and individual detection of Arterial Fibrillation
Fiona Johnston - Improving Detection & Management of Atrial Fibrillation after Ischaemic Stroke
Tilly Hamilton - Age specific performance of ASSIGN risk score for predicting cardiovascular events
Kayley Scott - Magnesium Sulphate Treatment During Hypertensive Pregnancy
Vishal Musale - Pirfenidone improves insulin sensitivity & cardiac function in obese mice
Dr. Carmel McEniery - The rise and rise of wearable technology, and what to do with it
Prof. Calum MacRae - David on Goliath’s shoulders – how big data will inform healthcare
SHARP Prize 2021 winners and closing remarks
This event was funded by the companies mentioned through event sponsorship and sponsored sessions for which we are very grateful.
Other than their own sessions, these companies had no input into the design or content of the agenda but were in attendance on the day. Furthermore, the Bristol-Myers Squibb/Pfizer Alliance had funded and organised the sponsored lunchtime session on the agenda.